CTX LIFE SCIENCES PVT LTD

Overview

CTX LIFE SCIENCES PVT LTD is an active pharmaceutical ingredient (API) supplier with 51 active FDA Type II Drug Master Files, covering (R)-2-(4-NITRO PHENETHYL AMINO)-1-PHENYL ETHANOL/MRG4BASEP; 3-NITRO-4-(((TETRAHYDRO-2H-PYRAN-4-YL) METHYL) AMINO) BENZENE SULFONAMIDE; 4-FLUORO-1-ISOPROPYL-2-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-Y1)-1H-BENZO[D]IMIDAZOLE/AMA-3; 4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID/IVF-3P; 8-BROMO-7-(BUT-2-YN-1-YL)-3-METHYL-3,7-DIHYDRO-1H-PURINE-2,6-DIONE; ACETAZOLAMIDE USP.

API / Drug Master Files

CTX LIFE SCIENCES PVT LTD holds 51 active (67 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ETHYL-2-(7-(4-CYCLOPENTYL-3-(TRIFLUORO- METHYL)BENZYLOXY)-1,2,3,4-TETRA HYDRO- CYCLOPENTA[B]INDOL-3-YL)ACETATE/ETC-4Active2026-02-25
• EMPAGLIFLOZINActive2025-12-18
• LINAGLIPTINActive2025-10-15
• 4-FLUORO-1-ISOPROPYL-2-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-Y1)-1H-BENZO[D]IMIDAZOLE/AMA-3Active2025-10-13
• LANREOTIDE ACETATEActive2025-09-11
• ALOGLIPTIN BENZOATE IHActive2025-06-25
• CLONIXIN-LYSINATEActive2025-06-20
• SAXAGLIPTIN INTERMEDIATE STAGE-I [CAS # 709031-43-6]Active2024-12-17
• APIXABAN (ROUTE-I)Active2024-10-18
• 8-BROMO-7-(BUT-2-YN-1-YL)-3-METHYL-3,7-DIHYDRO-1H-PURINE-2,6-DIONEActive2024-06-19
• TELMISARTAN USPActive2024-05-27
• OLMESARTAN MEDOXOMIL USPActive2024-04-16
• ROSUVASTATIN CALCIUM USPActive2023-12-21
• CHLORTHALIDONE USPActive2023-12-05
• DEFERASIROXActive2023-10-25

Showing 15 of 67 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CTX LIFE SCIENCES PVT LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.